{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T03:36:41Z","timestamp":1777952201914,"version":"3.51.4"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["BioSystems"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.biosystems.2026.105750","type":"journal-article","created":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T08:47:56Z","timestamp":1772095676000},"page":"105750","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Synergizing artificial intelligence with in vivo CAR-T cell generation: A new paradigm for\n                        democratized immunotherapy"],"prefix":"10.1016","volume":"262","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3374-0238","authenticated-orcid":false,"given":"Alberto","family":"Boretti","sequence":"first","affiliation":[]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.biosystems.2026.105750_bib1","article-title":"In vivo generated human CAR T cells eradicate tumor cells","volume":"8","author":"Agarwal","year":"2019","journal-title":"OncoImmunology"},{"issue":"1","key":"10.1016\/j.biosystems.2026.105750_bib2","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1186\/s13045-024-01625-7","article-title":"Optimizing CAR-T cell therapy for solid tumors: current challenges and potential\n                            strategies","volume":"17","author":"Ai","year":"2024","journal-title":"J. Hematol. Oncol."},{"issue":"1","key":"10.1016\/j.biosystems.2026.105750_bib3","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1038\/nbt.4317","article-title":"Predicting the mutations generated by repair of Cas9-induced double-strand breaks","volume":"37","author":"Allen","year":"2019","journal-title":"Nat. Biotechnol."},{"issue":"17","key":"10.1016\/j.biosystems.2026.105750_bib4","doi-asserted-by":"crossref","first-page":"2917","DOI":"10.3390\/cancers17172917","article-title":"Expanding immunotherapy beyond CAR T cells: engineering diverse immune cells to\n                            target solid tumors","volume":"17","author":"Andreou","year":"2025","journal-title":"Cancers"},{"key":"10.1016\/j.biosystems.2026.105750_bib5","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1635159","article-title":"Smart CAR-T Nanosymbionts: archetypes and proto-models","volume":"16","author":"Baena","year":"2025","journal-title":"Front. Immunol."},{"issue":"7","key":"10.1016\/j.biosystems.2026.105750_bib6","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1158\/2159-8290.CD-23-0010","article-title":"In synergy: optimizing CAR T development and personalizing patient care using\n                            single-cell technologies","volume":"13","author":"Barboy","year":"2023","journal-title":"Cancer Discov."},{"key":"10.1016\/j.biosystems.2026.105750_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiomed.2024.109137","article-title":"The transformative potential of AI-driven CRISPR-Cas9 genome editing to enhance\n                            CAR T-cell therapy","volume":"182","author":"Boretti","year":"2024","journal-title":"Comput. Biol. Med."},{"key":"10.1016\/j.biosystems.2026.105750_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2024.176618","article-title":"Improving chimeric antigen receptor T-cell therapies by using artificial\n                            intelligence and internet of things technologies: a narrative review","author":"Boretti","year":"2024","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.biosystems.2026.105750_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.biosystems.2025.105562","article-title":"The question of quantum communication between cancer cells","author":"Boretti","year":"2025","journal-title":"Biosystems"},{"key":"10.1016\/j.biosystems.2026.105750_bib10","series-title":"Science's Breakthrough of the Year 2013","article-title":"Cancer immunotherapy","author":"Coontz","year":"2013"},{"issue":"22","key":"10.1016\/j.biosystems.2026.105750_bib11","first-page":"5702","article-title":"Combining T-cell-specific activation and in vivo gene delivery through\n                            CD3-targeted lentiviral vectors","volume":"4","author":"Frank","year":"2020","journal-title":"Blood Adv."},{"issue":"20","key":"10.1016\/j.biosystems.2026.105750_bib12","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202501095","article-title":"From multi-omics to visualization and beyond: bridging micro and macro insights\n                            in CAR-T cell therapy","volume":"12","author":"Gong","year":"2025","journal-title":"Adv. Sci."},{"issue":"6753","key":"10.1016\/j.biosystems.2026.105750_bib13","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1126\/science.ads8473","article-title":"In vivo CAR T cell generation to treat cancer and autoimmune disease","volume":"388","author":"Hunter","year":"2025","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.biosystems.2026.105750_bib14","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s10020-025-01085-w","article-title":"Single cell RNA sequencing improves the next generation of approaches to AML\n                            treatment: challenges and perspectives","volume":"31","author":"Khosroabadi","year":"2025","journal-title":"Mol. Med."},{"issue":"6","key":"10.1016\/j.biosystems.2026.105750_bib15","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/s41551-018-0235-9","article-title":"Programming CAR-T cells to kill cancer","volume":"2","author":"Labanieh","year":"2018","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.biosystems.2026.105750_bib16","article-title":"Neuroimmunology-driven CAR T-cell therapeutics for gliomas: translational\n                            challenges and clinical trial paradigm innovation","author":"Li","year":"2025","journal-title":"Cancer Lett."},{"key":"10.1016\/j.biosystems.2026.105750_bib17","doi-asserted-by":"crossref","DOI":"10.1126\/science.aee6253","article-title":"The first patients have been helped by cancer-fighting cells made directly in\n                            their bodies","author":"Leslie","year":"2025","journal-title":"Science"},{"key":"10.1016\/j.biosystems.2026.105750_bib18","article-title":"New approach enables body to engineer its own cells to fight cancer or\n                            autoimmunity","author":"Leslie","year":"2025","journal-title":"Science"},{"key":"10.1016\/j.biosystems.2026.105750_bib19","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.omtm.2016.12.006","article-title":"Global manufacturing of CAR T cell therapy","volume":"4","author":"Levine","year":"2017","journal-title":"Mol. Ther., Methods Clin. Dev."},{"key":"10.1016\/j.biosystems.2026.105750_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.nantod.2024.102518","article-title":"In situ engineering of mRNA-CAR T cells using spleen-targeted ionizable lipid\n                            nanoparticles to eliminate cancer cells","volume":"59","author":"Li","year":"2024","journal-title":"Nano Today"},{"key":"10.1016\/j.biosystems.2026.105750_bib21","article-title":"Making CRISPR-Cas9 gene editing safer with artificial intelligence","author":"Liu","year":"2018","journal-title":"FierceBiotech"},{"issue":"1","key":"10.1016\/j.biosystems.2026.105750_bib22","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/s12929-025-01190-2","article-title":"Technological advancements in antibody-based therapeutics for treatment of\n                            diseases","volume":"32","author":"Lu","year":"2025","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.biosystems.2026.105750_bib23","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1038\/s41408-021-00508-1","article-title":"AAV-Mediated in vivo CAR gene therapy for targeting human T-cell leukemia","volume":"11","author":"Nawaz","year":"2021","journal-title":"Blood Cancer J."},{"issue":"11","key":"10.1016\/j.biosystems.2026.105750_bib24","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1182\/blood.2024024523","article-title":"In vivo CAR T-cell generation in nonhuman Primates using lentiviral vectors\n                            displaying a multidomain fusion ligand","volume":"144","author":"Nicolai","year":"2024","journal-title":"Blood"},{"key":"10.1016\/j.biosystems.2026.105750_bib25","doi-asserted-by":"crossref","first-page":"6080","DOI":"10.1038\/s41467-020-19486-2","article-title":"In vitro-transcribed antigen receptor mRNA nanocarriers for transient expression\n                            in circulating T cells in vivo","volume":"11","author":"Parayath","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biosystems.2026.105750_bib26","article-title":"Profluent combines LLMs and CRISPR for open-source AI gene editing project","year":"2024","journal-title":"FierceBiotech"},{"issue":"6576","key":"10.1016\/j.biosystems.2026.105750_bib27","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1126\/science.abm0594","article-title":"CAR T cells produced in vivo to treat cardiac injury","volume":"375","author":"Rurik","year":"2022","journal-title":"Science"},{"issue":"Part 2","key":"10.1016\/j.biosystems.2026.105750_bib28","article-title":"In vivo nano-engineering T cells for CAR-T therapy","volume":"388","author":"Shi","year":"2025","journal-title":"J. Contr. Release"},{"issue":"8","key":"10.1016\/j.biosystems.2026.105750_bib29","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1038\/nnano.2017.57","article-title":"In situ programming of leukaemia-specific T cells using synthetic DNA\n                            nanocarriers","volume":"12","author":"Smith","year":"2017","journal-title":"Nat. Nanotechnol."},{"issue":"4","key":"10.1016\/j.biosystems.2026.105750_bib30","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/s41408-021-00459-7","article-title":"CAR-T cell therapy: current limitations and potential strategies","volume":"11","author":"Sterner","year":"2021","journal-title":"Blood Cancer J."},{"key":"10.1016\/j.biosystems.2026.105750_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2025.218014","article-title":"Cell adhesion molecule ITGB2 promotes CAR-T cell therapy in B-cell malignancies","author":"Su","year":"2025","journal-title":"Cancer Lett."},{"issue":"11","key":"10.1016\/j.biosystems.2026.105750_bib33","doi-asserted-by":"crossref","first-page":"3293","DOI":"10.1016\/j.ymthe.2021.06.004","article-title":"Highly efficient CD4+ T cell targeting and genetic recombination using engineered\n                            CD4+ cell-homing mRNA-LNPs","volume":"29","author":"Tombacz","year":"2021","journal-title":"Mol. Ther."},{"key":"10.1016\/j.biosystems.2026.105750_bib34","series-title":"The AI-Driven CAR-T Design Arrives","author":"Wang","year":"2024"},{"key":"10.1016\/j.biosystems.2026.105750_bib35","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1056\/NEJMc2509522","article-title":"In vivo CD19 CAR T-Cell therapy for refractory systemic lupus erythematosus","volume":"393","author":"Wang","year":"2025","journal-title":"N. Engl. J. Med."},{"issue":"10438","key":"10.1016\/j.biosystems.2026.105750_bib36","first-page":"1234","article-title":"In vivo generation of anti-BCMA CAR-T cells via lentiviral vector in patients\n                            with relapsed\/refractory multiple myeloma: a first-in-human study","volume":"405","author":"Xu","year":"2025","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.biosystems.2026.105750_bib37","first-page":"454","article-title":"The landscape of CAR-T cell therapy in China: clinical progress and industrial\n                            development","volume":"8","author":"Zhang","year":"2023","journal-title":"Signal Transduct. Targeted Ther."},{"issue":"1","key":"10.1016\/j.biosystems.2026.105750_bib38","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1186\/s12967-025-07249-w","article-title":"Synergistic innovations of nanomedicine in lymphoma treatment: a systematic\n                            review","volume":"23","author":"Zhang","year":"2025","journal-title":"J. Transl. Med."},{"issue":"1","key":"10.1016\/j.biosystems.2026.105750_bib39","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1186\/s12943-025-02411-w","article-title":"Advances and obstacles of T cell-based immunotherapy in gynecological\n                            malignancies","volume":"24","author":"Zhao","year":"2025","journal-title":"Mol. Cancer"},{"issue":"5","key":"10.1016\/j.biosystems.2026.105750_bib40","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.4049\/jimmunol.1500956","article-title":"Exclusive transduction of human CD4+ T cells upon systemic delivery of\n                            CD4-targeted lentiviral vectors","volume":"195","author":"Zhou","year":"2015","journal-title":"J. Immunol."}],"container-title":["BioSystems"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303264726000602?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303264726000602?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T11:51:37Z","timestamp":1777895497000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0303264726000602"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":39,"alternative-id":["S0303264726000602"],"URL":"https:\/\/doi.org\/10.1016\/j.biosystems.2026.105750","relation":{},"ISSN":["0303-2647"],"issn-type":[{"value":"0303-2647","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Synergizing artificial intelligence with in\n                            vivo CAR-T cell generation: A new paradigm for democratized immunotherapy","name":"articletitle","label":"Article Title"},{"value":"BioSystems","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biosystems.2026.105750","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00c2\u00a9 2026 Elsevier B.V. All rights are reserved,\n                            including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"105750"}}